BiotechTube
iNanoBio

iNanoBio

Cambridge, United States· Est.
inanobio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

iNanoBio is a private, pre-revenue biotech company founded in 2018 and based in Cambridge, Massachusetts (with a noted Arizona connection). It leverages a proprietary FDEC FET nano sensor technology to target two major applications: a next-generation, CMOS-based 3D nanopore genome sequencer and liquid biopsy diagnostics for early cancer detection. The company is bolstered by a high-profile scientific advisory board, including pioneers like Dr. George Church and Dr. Chenming Hu, and is actively presenting at industry conferences to advance its technology and seek partnerships.

OncologyNeurology

Technology Platform

FDEC FET nano sensor technology; a CMOS-compatible, solid-state 3D nanopore-transistor device for ultra-sensitive chemical/biological sensing and DNA sequencing.

Opportunities

The convergence of low-cost, high-speed sequencing and ultra-sensitive liquid biopsy creates a massive opportunity in precision medicine and preventive healthcare.
A successful platform could enable population-scale genomics and routine multi-cancer early detection screening, dramatically improving patient outcomes and reducing healthcare costs.

Risk Factors

High technical risk in scaling a novel nano sensor from lab to robust product.
Intense competition from well-funded incumbents in sequencing (Illumina, Oxford Nanopore) and diagnostics.
Significant regulatory hurdles and capital requirements for clinical validation and commercialization.

Competitive Landscape

In sequencing, iNanoBio faces entrenched competitors like Illumina (short-read) and Oxford Nanopore (long-read). In liquid biopsy, it competes with giants like Grail, Exact Sciences, and Freenome. Its differentiation hinges on the performance (speed, cost, sensitivity) of its proprietary FDEC/CMOS-based sensor technology, which is unproven at commercial scale.

More companies in Diagnostics & Precision Medicine →More companies in United States →